CS99 - No disagreement about useless data at all. In the past the ALP reduction was dismissed as useless data as well. A number of pharma investors wrote RVX off in the early years as well because they didn't first, define their methods of action. It was said by some that this whole story was bogus because some people could not wrap their heads around the " new class of drug " theory and consequently wrote off everything after ASSERT as useless information.

Every new data set may allow for new theories to be developed. For that reason alone I would like to see any data may become available, simply out of interest, even if it is classified as useless.

tada